Insmed reports positive topline results from phase 3b ENCORE study of Arikayce in patients with MAC lung disease: Bridgewater, New Jersey Wednesday, March 25, 2026, 17:00 Hrs [IST ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results